This bill would require employer group health plans and group health insurance that already cover obstetrical services to also cover infertility and iatrogenic infertility treatments. It defines "infertility" and "iatrogenic infertility" and lists treatments that must be covered, including in vitro fertilization, egg and sperm cryopreservation, intrauterine insemination, ovulation induction, and genetic testing. The bill allows standard fertility preservation when certain medical treatments (for example, surgery involving reproductive organs, radiation, chemotherapy, or myeloablative conditioning) cause or are expected to cause infertility.
The bill says coverage limits and cost-sharing (copays, coinsurance, deductibles, preauthorization) may apply but must not be more restrictive than the main medical and surgical benefits in the plan. Plans and issuers may not give incentives to discourage people from using these benefits, may not stop providers from discussing these treatments with patients, and may not reduce provider reimbursement for providing covered fertility services.
The bill requires plans that use utilization management tools on fertility benefits to perform and document analyses of those tools for the first five plan years after enactment and to submit the analyses to the federal Secretary. The Secretary can review, demand corrections, require plans to notify enrollees if a final noncompliance finding is made, and must report to Congress and the public about compliance beginning with plan years on or after January 1, 2027. Civil penalties of up to $100 per day per person are authorized for wrongful denials and for failing to submit required analyses. The section would take effect for plan years beginning on or after January 1, 2027.
No publicly available information on proponents' stated views or legislative findings is included in the bill text or the provided metadata.
No publicly available information on opponents' stated views or concerns is included in the bill text or the provided metadata.